REPL Competitors & Alternatives
Compare Replimune Group Inc with similar stocks in the same industry
Biotechnology
REPL
Main Stock$5.01
Tradestie Score
57
Market Cap
$328.62M
Analyst Upside
-30.1%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.64
|
$474.20M | 26.6 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$4.95
|
$468.01M | - | 57 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.01
|
$463.20M | - | 54 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$6.51
|
$457.09M | - | 50 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$4.08
|
$454.29M | - | 57 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$16.44
|
$448.32M | - | 52 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$21.15
|
$422.50M | - | 59 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$75.00
|
$410.79M | - | 48 | Compare |
More REPL Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry